Moreover, P2rx7 deletion or Brilliant Blue G (BBG) administration hampered T1D development in mice treated with STZ; both conditions led to reduced hyperglycemia, islet destruction, and leukocyte infiltration in the parenchyma and pancreatic lymph nodes [130]. The gene discussed is P2RX7; the disease is type 1 diabetes mellitus.